Osteoporosis: all 1,675 studies
Page 14 of 17. Open to participants first (211), then studies with results posted, then the rest; newest registration first within each.
- Postural Assessment by PhotogrammetryCompletedNCT00848159
- Women's Health Habits StudyCompletedNCT00846638Phase 3
- A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female SubjectsCompletedNCT00846196Phase 1
- Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed OsteoporosisCompletedNCT00838838
- Analysis of Iliac Crest Biopsies From Patients Receiving RisedronateCompletedNCT00837746
- Influence of Bone Strength Measured by DensiProbe on Bone Related Fixation FailureTerminatedNCT00822159Not applicable
- Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral PalsyTerminatedNCT00822029Phase 3
- Estimation of Osteoporosis' Prevalence in France: Pilot Study in the Department of the Alpes-MaritimesCompletedNCT00821925Not applicable
- Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate CancerCompletedNCT00816452
- Pharmacokinetic, Safety and Tolerability Study of SC Administered Bisphosphonate With rHuPH20 vs Bisphosphonate AloneCompletedNCT00807963Phase 1
- Zoledronate for Osteopenia in Pediatric Crohn'sCompletedNCT00798473Phase 3
- Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' CohortCompletedNCT00795483Phase 4
- ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis PatientsCompletedNCT00794443Phase 2/3
- Risedronate vs Raloxifene in Hormone Replacement Therapy DiscontinuationTerminatedNCT00790101Phase 4
- Investigating the Effect of Standardized Olive Extract on Bone Turnover Markers in Postmenopausal WomenCompletedNCT00789425Phase 2
- Improving Care of Osteoporosis: Multi-Modal Intervention to Increase Testing and Treatment (ICOMMIITT)CompletedNCT00788632Not applicable
- Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple SclerosisCompletedNCT00785473Phase 4
- Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or RisedronateCompletedNCT00778154
- A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)CompletedNCT00770159Phase 1
- Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)CompletedNCT00769418Phase 1
- An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily PracticeCompletedNCT00767585
- A Study of Arzoxifene to Treat Korean Women With OsteoporosisCompletedNCT00767299Phase 2
- Spine Quantitative Computed Tomography (QCT)CompletedNCT00762879
- The Interaction Between Calcium and Vitamin D IntakeCompletedNCT00762775Not applicable
- Back Pain in Patients With Severe OsteoporosisCompletedNCT00761332
- Growth Hormone Therapy and Bone Quality in Pediatric OsteoporosisCompletedNCT00757393Phase 3
- Feasibility of Doctors' Rooms-based Infusion of Zoledronic AcidCompletedNCT00745485Phase 4
- Effect of THAI Traditional Massage on Bone MarkersCompletedNCT00730600Not applicable
- Does Potassium Bicarbonate Improve the Effect of Dietary Protein on Bone and Muscle?CompletedNCT00730184Not applicable
- Milk Supplementation and Energy Balance.CompletedNCT00729170Not applicable
- Osteoporosis and Dental ImplantStatus unknownNCT00727493Phase 4
- Case Control Study: Determinants of Osteoporosis in GOLD II COPD Patients.CompletedNCT00725673
- An Interventional Study of Geriatric Frailty, Osteoporosis, and DepressionCompletedNCT00718432Not applicable
- A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal WomenCompletedNCT00709540Phase 1
- Does Bone Structure Explain the Increased Fracture Risk in Type II Diabetes Patients? A Pilot StudyCompletedNCT00703417
- Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy SubjectsCompletedNCT00699777Phase 1
- Investigation of the Effect of BONISTEIN(R) Bone Blend on Bone Mineral Density/Content and Biomarkers of Bone HealthCompletedNCT00698984Not applicable
- Cohort Study on Associations Between Purinergic Receptor SNPs and Osteoporosis RiskCompletedNCT00697983
- Bone Adaptation to Impact LoadingCompletedNCT00697957Not applicable
- A Study for Teriparatide in Severe OsteoporosisCompletedNCT00696644
- Vitamin B12 and Folic Acid Supplementation for Preventing Fractures in Elderly PeopleStatus unknownNCT00696514Phase 1
- Study of PH3 for the Prevention of Osteoporosis in Postmenopausal WomenCompletedNCT00693667Phase 2
- Vertebroplasty Using Real-Time, Fluoroscopy-Controlled, Catheter-Assisted, Low-Viscosity Cement InjectionStatus unknownNCT00689923
- Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3CompletedNCT00688246
- Improving Osteoporosis Care in High-Risk Home Health PatientsCompletedNCT00679198Not applicable
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal SubjectsCompletedNCT00676312Phase 1
- Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal WomenCompletedNCT00675688Phase 3
- The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine EvaluationCompletedNCT00674453Phase 2
- Long-term Nutritional Intervention Study to Determine How Protein Affects Calcium MetabolismCompletedNCT00671944Phase 1
- Effects of Teriparatide in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00670501Phase 3
- Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00670319Phase 3
- Cyclic Versus Daily Teriparatide on Bone MassStatus unknownNCT00668941Phase 2
- Soy and Isoflavones Effect on BoneCompletedNCT00668447Phase 4
- Steroid Induced Osteoporosis in Patients With Systemic Lupus ErythematosusCompletedNCT00668330Phase 4
- 3D Imaging of the Hip Using DXACompletedNCT00666640
- Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential EffectsCompletedNCT00666627Phase 2
- Safety and Effectiveness of Soy Phytoestrogens to Prevent Bone LossCompletedNCT00665860Not applicable
- The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With WarfarinCompletedNCT00665613
- Effects of DHEA/Exercise on Bone, Muscle and BalanceCompletedNCT00664053Phase 4
- Study of the Osteoprotector Effects of a Milk Product Based on Anthocyans and Enriched in Calcium and Vitamin DCompletedNCT00663221Phase 2
- Thiazolidinediones (TZD) Bone Loss and the Effects on Bone Marrow Differentiation and Osteoblast FormationCompletedNCT00663143
- Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients CohortWithdrawnNCT00662077Phase 4
- Effect of Soy Isoflavones on Bone Mineral Density and Physical Performance IndicesCompletedNCT00661856Not applicable
- Exercise for Physical Health in Men With Prostate CancerCompletedNCT00660686Not applicable
- Optimizing Body Composition & Health After Breast CancerCompletedNCT00659906Not applicable
- Exercise and Prevention of Hip FracturesCompletedNCT00655577Not applicable
- To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal FemalesCompletedNCT00651534Phase 1
- Bone Health in Type 1 DiabetesCompletedNCT00651196
- The Effect of Exercise in Postmenopausal Women with Low Bone DensityCompletedNCT00643331Phase 2
- Effectiveness of Automated Inpatient Endocrinology Consultation for Osteoporotic Hip FractureTerminatedNCT00643175
- 4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)CompletedNCT00641771Phase 1
- BREAST CANCER AND EXERCISECompletedNCT00639210Phase 3
- Effectiveness of Physiotherapy for Osteoporotic Spinal FractureCompletedNCT00638768Phase 2
- Percutaneous Vertebroplasty: Prophylactic Treatment of Adjacent VertebraSuspendedNCT00635297Not applicable
- Bone Mineral Density in Adult Survivors of Solid Pediatric CancersCompletedNCT00634816
- Effects of Omega-3 Fatty Acids on Bone and FrailtyStatus unknownNCT00634686Phase 4
- Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice WorkflowCompletedNCT00634608Not applicable
- A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With OsteoporosisCompletedNCT00632216Phase 4
- Fractures in the Elderly Population of El Salvador at Hospital Zacamil: Exploring Knowledge, Causes, Risk Factors, and OutcomesCompletedNCT00625599
- Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMDWithdrawnNCT00624481Phase 2
- Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid TherapyCompletedNCT00616694Phase 4
- Longitudinal Study of Bone Mineral Density in Survivors of Solid Pediatric CancersCompletedNCT00615485
- GIOP Prevention Among People With Rheumatoid ArthritisCompletedNCT00609830Not applicable
- Closing The Post Fracture Care Gap In ManitobaActive, not recruitingNCT00594789Not applicable
- OSTPRE-Fracture Prevention StudyCompletedNCT00592917Phase 4
- Strength Training for Older Breast Cancer SurvivorsCompletedNCT00591747Not applicable
- Effectiveness of an Educational Program in the Prevention of Osteoporosis and FracturesCompletedNCT00589615Not applicable
- Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast CancerCompletedNCT00587925Not applicable
- STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)CompletedNCT00583518Phase 4
- Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal WomenCompletedNCT00578981Not applicable
- Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral DoseCompletedNCT00577850Phase 1
- Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMOCompletedNCT00577421Phase 3
- Education for Osteoporosis in Persons With Existing FracturesCompletedNCT00575250Not applicable
- Hormonal and Bone Turnover Marker Response to an Acute Bout of Resistance or Plyometric ExerciseCompletedNCT00572871
- Glucocorticoids Promote Osteoclast SurvivalTerminatedNCT00572299
- Prevention of Osteoporosis in Breast Cancer SurvivorsCompletedNCT00567606Not applicable
- Evaluating Ways to Improve Medication Use Among People With OsteoporosisCompletedNCT00567294Phase 3
- A Study of SB751689 in Japanese Postmenopausal WomenCompletedNCT00554255Phase 1
- Satisfaction and Compliance of Risedronate in PMOCompletedNCT00549965Phase 4
- POWER Point of Care Effect on Satisfaction of TreatmentCompletedNCT00549068Phase 4